hrcak mascot   Srce   HID

Conference paper

PERSONALIZED PHARMACOTHERAPY IN PSYCHIATRY

Pavo Filaković ; University Department of Psychiatry, Clinical Hospital Osijek, Osijek, Croatia
Anamarija Petek ; University Department of Psychiatry, Clinical Hospital Osijek, Osijek, Croatia

Fulltext: english, pdf (256 KB) pages 341-346 downloads: 646* cite
APA 6th Edition
Filaković, P. & Petek, A. (2009). PERSONALIZED PHARMACOTHERAPY IN PSYCHIATRY. Psychiatria Danubina, 21 (3), 341-346. Retrieved from https://hrcak.srce.hr/49221
MLA 8th Edition
Filaković, Pavo and Anamarija Petek. "PERSONALIZED PHARMACOTHERAPY IN PSYCHIATRY." Psychiatria Danubina, vol. 21, no. 3, 2009, pp. 341-346. https://hrcak.srce.hr/49221. Accessed 24 Oct. 2021.
Chicago 17th Edition
Filaković, Pavo and Anamarija Petek. "PERSONALIZED PHARMACOTHERAPY IN PSYCHIATRY." Psychiatria Danubina 21, no. 3 (2009): 341-346. https://hrcak.srce.hr/49221
Harvard
Filaković, P., and Petek, A. (2009). 'PERSONALIZED PHARMACOTHERAPY IN PSYCHIATRY', Psychiatria Danubina, 21(3), pp. 341-346. Available at: https://hrcak.srce.hr/49221 (Accessed 24 October 2021)
Vancouver
Filaković P, Petek A. PERSONALIZED PHARMACOTHERAPY IN PSYCHIATRY. Psychiatria Danubina [Internet]. 2009 [cited 2021 October 24];21(3):341-346. Available from: https://hrcak.srce.hr/49221
IEEE
P. Filaković and A. Petek, "PERSONALIZED PHARMACOTHERAPY IN PSYCHIATRY", Psychiatria Danubina, vol.21, no. 3, pp. 341-346, 2009. [Online]. Available: https://hrcak.srce.hr/49221. [Accessed: 24 October 2021]

Abstracts
The hypothesis of each individual being special and different leading to heterogenity of diseases sets the ground for the concept of personalized medicine.
Personalized psychiatry follows the principles of personalized medicine. A constituent part of an individually adapted approach towards the psychiatric patient presents itself thorough personalized psychiatry. The development of pharmacogenomics and pharmacogenetics as well as the nanotechnology based on
them ensures implementation of personalized medicine principles in psychiatry to a greater extent than other medical disciplines. In the field of pharmacogenomics, the greatest advance was achieved by the study of genetic variability in drug metabolism. All the predispositions are now present for the implementation of
pharmacogenetic tests in routine practice. Pharmacogenetic testing for medications which are metabolised thorough two polymorph cytochromes P 450: CYP2D6 and CYP2C19 is of special significance due to their involvement in most adverse and ultrafast metabolism of psychopharmacs. The potential application of personalized
medicine in psychiatry, supported by pharmacogenetics and pharmacogenomics, are: personalized medication choice, personalized dosage, anticipation of possible side-effects individually and personalized follow-up treatment with rehabilitation.
The authors conclude how the development of pharmacogenomics and pharmacogenetics as well as the nanotechnology based on them, presents a step forward in creating a personalized therapeutic approach in psychiatry. However, the burden of applying the most appropriate therapeutic agent and medication tapering remains based on clinician decision. Pharmacogenetics can only help by
making therapeutic decisions with one less unknown element.

Keywords
personalized; pharmacotherapy; psychiatry; pharmacogenomics; pharmacogenetics

Hrčak ID: 49221

URI
https://hrcak.srce.hr/49221

Visits: 848 *